Anti-ganglioside GD1b,  (polyclonal antibody to GD1b, isotype IgG, IgM)Anti-ganglioside GD1b, (polyclonal antibody to GD1b, isotype IgG, IgM)
Move your mouse over image or click to enlarge

Anti-ganglioside GD1b, (polyclonal antibody to GD1b, isotype IgG, IgM)

Anti-ganglioside GD1b (polyclonal antibody to GD1b, isotype IgG, IgM)

Anti-ganglioside GD1b (anti-GD1b) is very useful in the identification of disialoganglioside GD1b and in immunotargeting cells expressing disialoganglioside GD1b. Several gangliosides have been found to have elevated expressions in tumor cells. Many therapeutic treatments of tumor cells are being investigated using antibodies to target cells that express these elevated levels of gangliosides. GD1b may be a target molecule for autoantibodies in some patients with acute sensory ataxic neuropathy.3 Anti-GD1b has been found in some patients with Guillain–Barré syndrome (a disorder affecting the peripheral nervous system) and may contribute to the pathogenesis of sensory disturbance and demyelination.4
Cat# Size Price Qty Buy
1964 50 ul £348.50

Additional Information

Property Value or Rating
Product Size 50 ul
Manufacturer Matreya, LLC
Formula Weight 0
Solvent none
Source rabbit
Purity serum, not purified
Analytical Methods ELISA, TLC immunoblotting
Solubility water
Physical Appearance Purified anti-ganglioside GD1b
Storage -20°C

1. H. Yoshino, et al. “Fucosyl-GM1 in Human Sensory Nervous Tissue Is a Target Antigen in Patients with Autoimmune Neuropathies” Journal of Neurochemistty, Vol. 61 pp. 658, 1993 
2. S. Kusunoki, et al. “Neuropathy and IgM paraproteinemia: Differential binding of IgM M-proteins to peripheral nerve glycolipids” Neurology, Vol. 37 pp. 1795, 1987 
3. C. Pan et al. “Acute sensory ataxic neuropathy associated with monospecific anti-GD1b IgG antibody” Neurology, vol. 57(7) pp. 1316-1318, 2001 
4. F. Notturno MD, C. Caporale MD, A. Uncini MD “Acute sensory ataxic neuropathy with antibodies to GD1b and GQ1b gangliosides and prompt recovery” Muscle & Nerve, Vol. 37(2) pg. 265–268, 2008

Related Documents